You are reviewing the chart of a 34-year-old female with a history of mild persistent asthma, maintained on low-dose fluticasone (Flovent) 110 mcg, two puffs twice daily. During a routine follow-up she reports using her albuterol (ProAir) rescue inhaler three to four times per week over the last two months for cough and chest tightness, and wakes with wheezing about twice per month. She has no limitations in daily activities. Her FEV1 is 82% predicted. What is the most appropriate next step in management?

Question

Accepted Answer

✅ D. Classify her asthma as not well controlled and step up controller therapy (increase ICS dose or add a LABA)
Per NAEPP criteria, asthma control is "well controlled" only when SABA use is ≤ 2 days per week (excluding preventive use before exercise), nighttime awakenings ≤ 2 per month, no activity limitations, and FEV1 ≥ 80%. This patient is using albuterol 3-4 times per week, which automatically reclassifies her as "not well controlled" regardless of her normal FEV1. The correct response is to step up controller therapy before reaching for more rescue medication — typical options are to move from low-dose ICS to medium-dose ICS, or to add a LABA (e.g., switch to fluticasone-salmeterol/Advair or fluticasone-vilanterol/Breo). SMART therapy (ICS-formoterol used for both control and rescue) is another excellent option at this step.

❌ A. Continue current regimen — her FEV1 is normal and asthma is well controlled
FEV1 alone does not define control. Symptom frequency (daytime and nighttime) and reliever use are the more sensitive indicators. With albuterol use > 2 days per week and nocturnal symptoms twice a month, she does NOT meet well-controlled criteria despite her normal FEV1.

❌ B. Prescribe a short course of oral prednisone 40 mg daily for 5 days
Oral corticosteroid bursts are reserved for acute exacerbations — rapid worsening of symptoms, peak flow drops > 20%, or a recent ED visit. This patient has chronic poor control, not an acute exacerbation, so chronic undertreatment is the problem and stepping up the daily controller is the right answer.

❌ C. Add montelukast (Singulair) 10 mg nightly as the next step
Montelukast is not first-line add-on therapy. The NAEPP preferred step-up from low-dose ICS is medium-dose ICS or adding a LABA (preferred), not a leukotriene antagonist. Montelukast also carries an FDA black-box warning for neuropsychiatric effects (agitation, depression, suicidal ideation, nightmares) and should be used cautiously.

:::important
Rule of 2s for asthma control: if a patient uses their rescue SABA > 2 days per week, wakes > 2 nights per month, or has > 2 oral steroid bursts per year, asthma is NOT well controlled — step up controller therapy. Overuse of SABA is a marker of undertreatment, not a treatment plan, and is independently associated with asthma-related death.
:::

Albuterol

✅ Indications

⚙️ Mechanism of Action

📏 Dosing

🚫 Contraindications

⚠️ Adverse Effects

🔬 Monitoring

💎 Board Pearls

Practice Questions

Related Drugs in This Class

Sources

Ready to practice?